A citation-based method for searching scientific literature

Aaron J Grossberg, Linda C Chu, Christopher R Deig, Eliot K Fishman, William L Hwang, Anirban Maitra, Daniel L Marks, Arnav Mehta, Nima Nabavizadeh, Diane M Simeone, Colin D Weekes, Charles R Thomas. CA Cancer J Clin 2020
Times Cited: 26







List of co-cited articles
98 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pancreatic cancer.
Jonathan D Mizrahi, Rishi Surana, Juan W Valle, Rachna T Shroff. Lancet 2020
161
26

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
23

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
Thierry Conroy, Françoise Desseigne, Marc Ychou, Olivier Bouché, Rosine Guimbaud, Yves Bécouarn, Antoine Adenis, Jean-Luc Raoul, Sophie Gourgou-Bourgade, Christelle de la Fouchardière,[...]. N Engl J Med 2011
23

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
Daniel D Von Hoff, Thomas Ervin, Francis P Arena, E Gabriela Chiorean, Jeffrey Infante, Malcolm Moore, Thomas Seay, Sergei A Tjulandin, Wen Wee Ma, Mansoor N Saleh,[...]. N Engl J Med 2013
19

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
15

Pancreatic cancer.
Jorg Kleeff, Murray Korc, Minoti Apte, Carlo La Vecchia, Colin D Johnson, Andrew V Biankin, Rachel E Neale, Margaret Tempero, David A Tuveson, Ralph H Hruban,[...]. Nat Rev Dis Primers 2016
622
15

Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.
Lola Rahib, Benjamin D Smith, Rhonda Aizenberg, Allison B Rosenzweig, Julie M Fleshman, Lynn M Matrisian. Cancer Res 2014
15


Genomic analyses identify molecular subtypes of pancreatic cancer.
Peter Bailey, David K Chang, Katia Nones, Amber L Johns, Ann-Marie Patch, Marie-Claude Gingras, David K Miller, Angelika N Christ, Tim J C Bruxner, Michael C Quinn,[...]. Nature 2016
15

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
Thierry Conroy, Pascal Hammel, Mohamed Hebbar, Meher Ben Abdelghani, Alice C Wei, Jean-Luc Raoul, Laurence Choné, Eric Francois, Pascal Artru, James J Biagi,[...]. N Engl J Med 2018
704
15

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.
Richard A Moffitt, Raoud Marayati, Elizabeth L Flate, Keith E Volmar, S Gabriela Herrera Loeza, Katherine A Hoadley, Naim U Rashid, Lindsay A Williams, Samuel C Eaton, Alexander H Chung,[...]. Nat Genet 2015
689
15

Therapeutic developments in pancreatic cancer: current and future perspectives.
John P Neoptolemos, Jörg Kleeff, Patrick Michl, Eithne Costello, William Greenhalf, Daniel H Palmer. Nat Rev Gastroenterol Hepatol 2018
292
11

Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies.
Aleksandra Adamska, Alice Domenichini, Marco Falasca. Int J Mol Sci 2017
216
11

Inflammation and cancer.
Lisa M Coussens, Zena Werb. Nature 2002
11

Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.
Vincent P Groot, Georgios Gemenetzis, Alex B Blair, Roberto J Rivero-Soto, Jun Yu, Ammar A Javed, Richard A Burkhart, Inne H M Borel Rinkes, I Quintus Molenaar, John L Cameron,[...]. Ann Surg 2019
83
11

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
11

Pancreatic cancer.
Terumi Kamisawa, Laura D Wood, Takao Itoi, Kyoichi Takaori. Lancet 2016
11

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.
Shuji Isaji, Shugo Mizuno, John A Windsor, Claudio Bassi, Carlos Fernández-Del Castillo, Thilo Hackert, Aoi Hayasaki, Matthew H G Katz, Sun-Whe Kim, Masashi Kishiwada,[...]. Pancreatology 2018
186
11

Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial.
Janet E Murphy, Jennifer Y Wo, David P Ryan, Wenqing Jiang, Beow Y Yeap, Lorraine C Drapek, Lawrence S Blaszkowsky, Eunice L Kwak, Jill N Allen, Jeffrey W Clark,[...]. JAMA Oncol 2018
192
11

Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update.
Alok A Khorana, Shannon E McKernin, Jordan Berlin, Theodore S Hong, Anirban Maitra, Cassadie Moravek, Matthew Mumber, Richard Schulick, Herbert J Zeh, Matthew H G Katz. J Clin Oncol 2019
48
11

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.
John P Neoptolemos, Daniel H Palmer, Paula Ghaneh, Eftychia E Psarelli, Juan W Valle, Christopher M Halloran, Olusola Faluyi, Derek A O'Reilly, David Cunningham, Jonathan Wadsley,[...]. Lancet 2017
787
11

Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.
Eric A Collisson, Anguraj Sadanandam, Peter Olson, William J Gibb, Morgan Truitt, Shenda Gu, Janine Cooc, Jennifer Weinkle, Grace E Kim, Lakshmi Jakkula,[...]. Nat Med 2011
807
11


Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.
Julie R Brahmer, Scott S Tykodi, Laura Q M Chow, Wen-Jen Hwu, Suzanne L Topalian, Patrick Hwu, Charles G Drake, Luis H Camacho, John Kauh, Kunle Odunsi,[...]. N Engl J Med 2012
11

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
H A Burris, M J Moore, J Andersen, M R Green, M L Rothenberg, M R Modiano, M C Cripps, R K Portenoy, A M Storniolo, P Tarassoff,[...]. J Clin Oncol 1997
11

Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.
Michelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, Karen Ng, Eugenia Flores Figueroa, Grainne M O'Kane, Ashton A Connor, Robert E Denroche, Robert C Grant, Jessica McLeod,[...]. Nat Genet 2020
93
11

Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma.
Jia-Qiao Fan, Meng-Fei Wang, Hai-Long Chen, Dong Shang, Jugal K Das, Jianxun Song. Mol Cancer 2020
25
12

Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial.
Eileen M O'Reilly, Do-Youn Oh, Neesha Dhani, Daniel J Renouf, Myung Ah Lee, Weijing Sun, George Fisher, Aram Hezel, Shao-Chun Chang, Gordana Vlahovic,[...]. JAMA Oncol 2019
112
11

Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.
E Giovannetti, C L van der Borden, A E Frampton, A Ali, O Firuzi, G J Peters. Semin Cancer Biol 2017
51
7

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.
Elisa Giovannetti, Mario Del Tacca, Valentina Mey, Niccola Funel, Sara Nannizzi, Sergio Ricci, Cinzia Orlandini, Ugo Boggi, Daniela Campani, Marco Del Chiaro,[...]. Cancer Res 2006
274
7

Pancreatic tumors show high levels of hypoxia.
A C Koong, V K Mehta, Q T Le, G A Fisher, D J Terris, J M Brown, A J Bastidas, M Vierra. Int J Radiat Oncol Biol Phys 2000
351
7

Molecular subtypes of pancreatic cancer.
Eric A Collisson, Peter Bailey, David K Chang, Andrew V Biankin. Nat Rev Gastroenterol Hepatol 2019
179
7

Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.
Hayato Fujita, Kenoki Ohuchida, Kazuhiro Mizumoto, Soichi Itaba, Tetsuhide Ito, Kohei Nakata, Jun Yu, Tadashi Kayashima, Ryota Souzaki, Tatsuro Tajiri,[...]. Neoplasia 2010
116
7

Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix.
Mikaël M Martino, Priscilla S Briquez, Adrian Ranga, Matthias P Lutolf, Jeffrey A Hubbell. Proc Natl Acad Sci U S A 2013
254
7


Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis.
Chuanke Zhao, Yahui Su, Jianzhi Zhang, Qin Feng, Like Qu, Lixin Wang, Caiyun Liu, Beihai Jiang, Lin Meng, Chengchao Shou. Cancer Sci 2015
17
11

Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis.
C Perisanidis, A Psyrri, E E Cohen, J Engelmann, G Heinze, B Perisanidis, A Stift, M Filipits, G Kornek, E Nkenke. Cancer Treat Rev 2015
93
7

Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity.
Sheng Zheng, Jian Shen, Yang Jiao, Yan Liu, Chunmei Zhang, Min Wei, Shui Hao, Xianlu Zeng. Cancer Sci 2009
104
7

Immunity, inflammation, and cancer.
Sergei I Grivennikov, Florian R Greten, Michael Karin. Cell 2010
7

Fibrinogen signal transduction as a mediator and therapeutic target in inflammation: lessons from multiple sclerosis.
R A Adams, C Schachtrup, D Davalos, I Tsigelny, K Akassoglou. Curr Med Chem 2007
106
7

Elevated levels of plasma fibrinogen in patients with pancreatic cancer: possible role of a distant metastasis predictor.
Qingqu Guo, Bo Zhang, Xin Dong, Qiuping Xie, Enqi Guo, Hai Huang, Yulian Wu. Pancreas 2009
54
7

Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study.
Yi-Jun Shu, Hao Weng, Run-Fa Bao, Xiang-Song Wu, Qian Ding, Yang Cao, Xu-An Wang, Fei Zhang, Shan-Shan Xiang, Huai-Feng Li,[...]. BMC Cancer 2014
70
7

Analysis of incidence and clinical outcomes in patients with thromboembolic events and invasive exocrine pancreatic cancer.
Andrew S Epstein, Gerald A Soff, Marinela Capanu, Christopher Crosbie, Manish A Shah, David P Kelsen, Brian Denton, Stuart Gardos, Eileen M O'Reilly. Cancer 2012
63
7

Cancer: Inflaming metastasis.
Alberto Mantovani. Nature 2009
443
7


Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages.
Sonja Gillen, Tibor Schuster, Christian Meyer Zum Büschenfelde, Helmut Friess, Jörg Kleeff. PLoS Med 2010
912
7

Roles for growth factors in cancer progression.
Esther Witsch, Michael Sela, Yosef Yarden. Physiology (Bethesda) 2010
251
7

Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS).
Maximilian Bockhorn, Faik G Uzunoglu, Mustapha Adham, Clem Imrie, Miroslav Milicevic, Aken A Sandberg, Horacio J Asbun, Claudio Bassi, Markus Büchler, Richard M Charnley,[...]. Surgery 2014
419
7

The role of fibrinogen and related fragments in tumour angiogenesis and metastasis.
Carolyn A Staton, Nicola J Brown, Claire E Lewis. Expert Opin Biol Ther 2003
74
7

Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer.
Liming Sheng, Min Luo, Xiaojiang Sun, Nengming Lin, Weimin Mao, Dan Su. Int J Cancer 2013
69
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.